Table 3

Bleeding site

P2Y12i
n=297
Aspirin
n=778
Major
n (%)
Non-major
n (%)
Major
n (%)
Non-major
n (%)
Intracranial haemorrhage other than haemorrhagic stroke
(subarachnoid haemorrhage, subdural haematoma, extradural haematoma)
2 (0.7)0 (0)5 (0.6)0 (0)
Intrathecal bleeding0 (0)0 (0)0 (0)0 (0)
Intraocular bleeding1 (0.3)0 (0)6 (0.8)0 (0)
Intrapericardial haemorrhage0 (0)0 (0)0 (0)0 (0)
Intraarticular bleeding1 (0.3)0 (0)2 (0.3)0 (0)
Muscle haemorrhage accompanied by compartment syndrome0 (0)0 (0)0 (0)0 (0)
Retroperitoneal haemorrhage0 (0)0 (0)0 (0)0 (0)
Gastrointestinal bleeding6 (2.0)9 (3.0)19 (2.4)15 (1.9)
Subcutaneous bleeding0 (0)15 (5.1)3 (0.4)36 (4.6)
Nasal bleeding0 (0)11 (3.7)1 (0.1)32 (4.1)
Faecal occult blood0 (0)4 (1.3)0 (0)11 (1.4)
Others3 (1.0)19 (6.4)8 (1.0)69 (8.9)
Non-site-specific haemorrhages0 (0)0 (0)1 (0.1)1 (0.1)
  • P2Y12i, P2Y12 inhibitor.